Mitchell Glass MD Overview
- Company
- TNF Pharmaceutic...
- Primary Position
-
Chief Medical Of...
- Active Board Seats
-
1
Mitchell Glass MD General Information
Biography
Dr. Mitchell Glass serves as President & Chief Medical Officer at MyMD Pharmaceuticals. he serves as Principal at Medpro Investors. He served as Chief Medical Officer at Strados Labs. He served as Director & Executive Vice President, Research & Development at Invion. He serves as Principal at Medpro Investors. He is a 25-year veteran of the pharmaceutical industry. His experience is broad:- ranging from senior positions in top ten pharmaceutical companies to investment in and management of start-ups and biotechs. After seven years of research, teaching and patient care at the University of Pennsylvania, he joined ICI Pharmaceuticals in 1988 where he established the pulmonary therapeutics group and led the development and submission of the anti leukotriene ACCOLATE®. From 1995-6, he was Vice President and Director at SmithKline Beecham where he was responsible for cardiovascular, respiratory, renal and metabolic drug development and commercialization, including submission of the NDA/MAA for COREG®. From 1998 to 2003,he was Chief Medical Officer and VP of Clinical Development and Regulatory Affairs of AtheroGenics Inc. (AGIX), where he led product development from IND to initiation of Phase 3 for AGI1067 and was a member of the IPO team. He joined AQUMEN Biopharmaceuticals KK and NA as CEO of AQUMEN NA and a Main Board Director. He graduated from the University of Chicago and is board certified in internal medicine, pulmonary and critical care medicine.
Contact Information
Address
- 855 North Wolfe Street
- Suite 623
- Baltimore, MD 21205
- United States
Mitchell Glass MD Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Medpro Investors | Investor | Principal | New York, NY | Venture Capital | |
TNF Pharmaceuticals | Company | Chief Medical Officer & Board Member | Baltimore, MD | Drug Discovery |
Mitchell Glass MD Board Seats (1)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
TNF Pharmaceuticals | Drug Discovery | Publicly Held | Corporation | Baltimore, MD |
Mitchell Glass MD Network (5)
Board Members (5)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Bill White | TNF Pharmaceuticals | Self | Baltimore, MD | |
Robert Schroeder | TNF Pharmaceuticals | Self | Baltimore, MD | |
TNF Pharmaceuticals | Self | Baltimore, MD | ||
TNF Pharmaceuticals | Self | Baltimore, MD | ||
TNF Pharmaceuticals | Self | Baltimore, MD |
Mitchell Glass MD FAQs
-
Who is Mitchell Glass MD?
Dr. Mitchell Glass serves as President & Chief Medical Officer at MyMD Pharmaceuticals.
-
How much does Mitchell Glass MD typically invest?
Mitchell Glass MD's median deal size is
. -
What is Mitchell Glass MD’s main position?
Mitchell Glass MD’s primary position is Chief Medical Officer & Board Member.
-
What are the contact details for Mitchell Glass MD?
Mitchell Glass MD’s email address is mi
and his phone number is +1 (813) . -
How many active board seats does Mitchell Glass MD hold?
Mitchell Glass MD holds a board seat in TNF Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »